Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/47232
FROM LABORATORY TO PATIENTS: DISSECTING OBSTACLES IN CELL & GENE THERAPY DEVELOPMENT
Author
Affilliation
Karolinska Institutet. Stockolm, Sweden / Health Institute of Technology. Serviço Nacional de Aprendizagem Industrial. CIMATEC, Salvador, BA, Brazil.
Rigenerand srl. Medolla. Italy.
Rigenerand srl. Medolla. Italy.
University. Hospital of Modena and Reggio Emilia. Modena, Italy.
Health Institute of Technology. Serviço Nacional de Aprendizagem Industrial. CIMATEC, Salvador, BA, Brazil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Bahia, Brasil.
Karolinska Institutet. Stockolm, Sweden.
Rigenerand srl. Medolla, Italy / University. Hospital of Modena and Reggio Emilia. Modena, Italy.
Rigenerand srl. Medolla. Italy.
Rigenerand srl. Medolla. Italy.
University. Hospital of Modena and Reggio Emilia. Modena, Italy.
Health Institute of Technology. Serviço Nacional de Aprendizagem Industrial. CIMATEC, Salvador, BA, Brazil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Bahia, Brasil.
Karolinska Institutet. Stockolm, Sweden.
Rigenerand srl. Medolla, Italy / University. Hospital of Modena and Reggio Emilia. Modena, Italy.
Share